Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

Many patients with diabetic kidney disease have residual albuminuria and are at risk of disease progression. The ALBUM trial investigated the efficacy of a novel, orally active inhibitor of vascular adhesion protein-1, ASP8232, compared with placebo for reducing albuminuria in individuals with type...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet. Diabetes & endocrinology 2018-12, Vol.6 (12), p.925-933
Hauptverfasser:	de Zeeuw, Dick, Renfurm, Ronny W, Bakris, George, Rossing, Peter, Perkovic, Vlado, Hou, Fan Fan, Nangaku, Masaomi, Sharma, Kumar, Heerspink, Hiddo J L, Garcia-Hernandez, Alberto, Larsson, Tobias E
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!